Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
about
Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pathophysiological aspects of ...... human erythropoietin therapy.
@en
Pathophysiological aspects of ...... human erythropoietin therapy.
@nl
type
label
Pathophysiological aspects of ...... human erythropoietin therapy.
@en
Pathophysiological aspects of ...... human erythropoietin therapy.
@nl
prefLabel
Pathophysiological aspects of ...... human erythropoietin therapy.
@en
Pathophysiological aspects of ...... human erythropoietin therapy.
@nl
P2093
P2860
P50
P356
P1476
Pathophysiological aspects of ...... t human erythropoietin therapy
@en
P2093
Apostolos C Kokkalis
Artemis I Voulgaridou
Effie G Papageorgiou
Hara T Georgatzakou
Issidora S Papassideri
Vassilis L Tzounakas
P2860
P304
P356
10.1111/EJH.12875
P577
2017-04-12T00:00:00Z